RUBY: HRQoL With Dostarlimab + CP in EC
ENGOT-EN6-NSGO/GOG-3031/RUBY: PROs With Addition of Dostarlimab to  Carboplatin/Paclitaxel for Advanced or Recurrent Endometrial Cancer

Released: June 09, 2023

Activity

Progress
1
Course Completed